Does long-term use of valproate cause weight gain in prepubertal epileptic children?

International Journal of Neuroscience

Volumn 112, Issue 10, 2002, Pages 1183-1189

  Çaksen, Hüseyin ^a   Deda, Gülhis ^a   Berberoǧlu, Merih ^a  

^a K Karabekir C Golbasi 3 S ^*  (Turkey)

Author keywords

Leptin; Valproate; Weight gain

Indexed keywords

ANTICONVULSIVE AGENT; LEPTIN; VALPROIC ACID;

ARTICLE; BLOOD; BODY MASS; CHILD; DRUG EFFECT; EPILEPSY; FEMALE; HUMAN; MALE; TIME; WEIGHT GAIN;

ANTICONVULSANTS; BODY MASS INDEX; CHILD; EPILEPSY; FEMALE; HUMANS; LEPTIN; MALE; TIME; VALPROIC ACID; WEIGHT GAIN;

EID: 0036805736     PISSN: 00207454     EISSN: None     Source Type: Journal    
DOI: 10.1080/00207450290026148     Document Type: Article

References (20)

1. Aicardi, J., Bax, M., Gillberg, C., & Ogier, H. (1998). Diseases of the Nervous System in Childhood. London: Mac Keith Press.
2. Breum, L., Astrup, A., Gram, L., Andersen, T., Stokholm, K. H., Christensen. N. J., Werdelin, L., & Madsen, J. (1992). Metabolic changes during treatment with valproate in humans: Implication for untoward weight gain. Metabolism, 41, 666-670.
3. Brodersen, R., Jorgensen, N., Vorum, H., & Krukow, N. (1990). Valproate and palmitate binding to human serum albumin: An hypothesis on obesity. Molecular Pharmacology, 37, 704-709.
4. Considine, R. V., Sinha, M. K., Heiman, M. L., Kriauciunas, A., Stephens, T. W., Nyce, M. R., Ohannesian, J. P., Marco, C. C., McKee, L. J., Bauer, T. L., & Caro, J. F. (1996). Serum immunoreactive leptin concentrations in normal-weight and obese humans. New England Journal of Medicine, 334, 292-295.
5. Corman, C. L., Leung, N. M., & Guberman, A. H. (1997). Weight gain in epileptic patients during treatment with valproic acid: A retrospective study. Canadian Journal of Neurological Science, 24, 240-244.
6. Covanis, A., Gupta, A. K., & Jeavons, PM. (1982). Sodium valproate: Monotherapy and polytherapy. Epilepsia, 23, 693-720.
7. Demir, E., & Aysun, S. (2000). Weight gain associated with valproate in childhood. Pediatric Neurology, 22, 361-364.
8. Dinesen, H., Gram, L., Andersen, T., & Dam, M. (1984). Weight gain during treatment with valproate. Acta Neurologica Scandihavica, 69, 65-69.
9. Easter, D., O'Bryan-Tear, C. G., & Verity, C. (1997). Weight gain with valproate or carbamazopine-A reappraisal. Seizure, 6, 121-125.
10. Egger, J., & Brett, E.M. (1981). Effects of sodium valproate in 100 children with special reference to weight. British Medical Journal (Clinical Research), 283, 577-581.
11. Haslam, R. H. A. (2000). The nervous system. In R. E. Behrman, R. M. Kliegman, & H. B. Jenson (Eds.), Textbook of Pediatrics (16th ed., pp. 1793-1866). Philadelphia: WB Saunders Co.
12. Isojarvi, J. I., Laatikainen, T. J., Knip, M., Pakarinen, A. J., Juntunen, K. T., & Myllyla, V. V. (1996). Obesity and endocrine diseases in women taking valproate for epilepsy. Annals of Neurology, 39, 579-584.
13. Isojarvi, J. I., Laatikainen, T. J., Pakarinen, A. J., Juntunen, K. T., & Myllyla, V. V. (1993). Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. New England Journal of Medicine, 329, 1383-1388.
14. Maffei, M., Halaas, J., Ravussin, E., Pratley, R. E., Lee, G. H., Zhang, Y., Fei, H., Kim, S., Lallone, R., Ranganathan, S., et al. (1995). Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Medicine, 1, 1155-1161.
15. Mantzoros, C. S., & Moschos, S. J. (1998). Leptin: In search of role(s) in human physiology and pathophysiology. Clinical Endocrinology, 49, 551-567.
16. Marshall, W. A., & Tanner, J. M. (1969). Variations in pattern of pubertal changes in girls. Archives of Diseases in Childhood, 44, 291-303.
17. Novak, G. P., Maytal, J., Alshansky, A., Eviatar, L., Sy-Kho, R., & Siddique, Q. (1999). Risk of excessive weight gain in epileptic children treated with valproate. Journal of Child Neurology, 14, 490-495.
18. Rogiers, V., Vandenberghe, Y., & Vercruysse, A. (1985). Inhibition of gluconeogenesis by sodium valproate and its metabolites in rat hepatocytes. Xenobiotica, 15, 759-765.
19. Verrotti, A., Basciani, F., Morresi, S., de Martino, M., Morgese, G., & Chiarelli, F. (1999). Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology, 53, 230-232.
20. Vorum, H., Gram, L., & Honore, B. (1993). Valproate and palmitate binding to serum albumin in valproate-treated patients: Relation to obesity. Epilepsy Research, 16, 55-64.